Aurora Cannabis (ACB) Amortizatization of Intangibles (2017 - 2025)
Aurora Cannabis (ACB) reported Amortizatization of Intangibles of $77357.7 for Q1 2025, down 11.66% year-over-year from $87569.4 in Q1 2024, and down 12.14% quarter-over-quarter from $88049.4 in Q4 2024.
Aurora Cannabis (ACB) Amortizatization of Intangibles (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Amortizatization of Intangibles data on file, last reported at $77357.7 in Q1 2025.
- Amortizatization of Intangibles for Q1 2025 came in at $77357.7, down 11.66% year-over-year; the trailing twelve-month figure through Mar 2025 was $429834.8 (down 37.03% YoY), and the FY2025 annual result was $414665.3, down 37.98% from the prior year.
- Amortizatization of Intangibles eased to $77357.7 in Q1 2025 per ACB's latest filing, from $88049.4 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $8.8 million in Q2 2021 and troughed at $77357.7 in Q1 2025.
- A 5-year average of $2.9 million and a median of $196699.7 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles tumbled 97.92% in 2022, then soared 47.27% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $6.7 million in 2021, then slumped by 97.04% to $196699.7 in 2022, then declined by 1.41% to $193917.4 in 2023, then tumbled by 54.59% to $88049.4 in 2024, then dropped by 12.14% to $77357.7 in 2025.
- Business Quant data shows ACB's Amortizatization of Intangibles at $77357.7 in Q1 2025, $88049.4 in Q4 2024, and $186195.6 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 242,000.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 77,357.73 |
| Mar 31, 2025 | 77,357.73 |
| Dec 31, 2024 | 88,049.44 |
| Dec 31, 2024 | 88,049.44 |
| Sep 30, 2024 | 186,195.57 |
| Sep 30, 2024 | 186,195.57 |
| Jun 30, 2024 | 78,232.04 |
| Jun 30, 2024 | 78,232.04 |
| Mar 31, 2024 | 87,569.36 |
| Mar 31, 2024 | 87,569.36 |
| Dec 31, 2023 | 193,917.38 |
| Dec 31, 2023 | 193,917.38 |
| Sep 30, 2023 | 204,384.95 |
| Sep 30, 2023 | 204,384.95 |
| Dec 31, 2022 | 196,699.68 |
| Dec 31, 2022 | 196,699.68 |
| Sep 30, 2022 | 138,781.07 |
| Sep 30, 2022 | 138,781.07 |
| Jun 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 6.52 Mn |